3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Large-Cell, Anaplastic
3
Immunoblastic Lymphadenopathy
3
Esophageal Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Sarcoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Rhabdoid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Interventions
Gemcitabine
13
Cisplatin
8
Capecitabine
8
Fluorouracil
5
pembrolizumab
4
Oxaliplatin
4
Sorafenib
3
Leucovorin
3
Erlotinib Hydrochloride
3
trametinib
2
regorafenib
2
durvalumab
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Magnetic Resonance Spectroscopy
2
Lapatinib
2
trifluridine tipiracil drug combination
1
tremelimumab
1
spartalizumab
1
seribantumab
1
olutasidenib
1
olaparib
1
devimistat
1
derazantinib
1
dehydroftorafur
1
cediranib
1
cabozantinib
1
Trifluridine
1
Trastuzumab
1
Therapeutics
1
Sutures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Bile Duct Neoplasms
×
Microarray Analysis
×
Clear all
No trials found.